Related references
Note: Only part of the references are listed.Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts
M. De Mattei et al.
OSTEOARTHRITIS AND CARTILAGE (2009)
Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis
Y. Z. Liu et al.
OSTEOARTHRITIS AND CARTILAGE (2009)
Topical Therapy for Osteoarthritis: Clinical and Pharmacologic Perspectives
Roy Altman et al.
POSTGRADUATE MEDICINE (2009)
The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis
Saski Sutton et al.
VETERINARY JOURNAL (2009)
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats
A. Ochaion et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Suppression of inflammatory and immune responses by the A2A adenosine receptor:: an introduction
T. M. Palmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Purinergic signalling and disorders of the central nervous system
Geoffrey Burnstock
NATURE REVIEWS DRUG DISCOVERY (2008)
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields
K. Varani et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
W. Zhang et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
The A(3) adenosine receptor: An enigmatic player in cell biology
Stefania Gessi et al.
PHARMACOLOGY & THERAPEUTICS (2008)
The Adenosine A2b Receptor: Its Role in Inflammation
J. Ham et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
P38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis
J. Westra et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Oxidative stress in marathon runners:: interest of antioxidant supplementation
Mari-Carmen Gomez-Cabrera et al.
BRITISH JOURNAL OF NUTRITION (2006)
Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-α production through inhibition of PI 3-kinase/Akt and NF-κB activation in murine BV2 microglial cells
JY Lee et al.
NEUROSCIENCE LETTERS (2006)
Activation of the adenosine A(3) receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappa B and extracellular signal-regulated kinase 1/2
L Martin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A selective small molecule I kappa B kinase beta inhibitor blocks nuclear factor kappa B- mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells
Danyi Wen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors
K Varani et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Adenosine is a negative regulator of NF-κB and MAPK signaling in human intestinal epithelial cells
HB Jijon et al.
CELLULAR IMMUNOLOGY (2005)
An adenosine A2A receptor agonist reduces interleukin-8 expression and glycosaminoglycan loss following septic arthrosis
SB Cohen et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2005)
Synovial tissue inflammation in early and late osteoarthritis
MJ Benito et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20
S Gessi et al.
MOLECULAR PHARMACOLOGY (2005)
Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis
BN Cronstein
PHARMACOLOGICAL REVIEWS (2005)
Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes
T Inoue et al.
JOURNAL OF IMMUNOLOGY (2005)
Expression of A3 adenosine receptors in human lymphocytes:: Up-regulation in T cell activation
S Gessi et al.
MOLECULAR PHARMACOLOGY (2004)
Activation of adenosine receptors inhibits tumor necrosis factor-α release by decreasing TNF-α mRNA stability and p38 activity
JA Fotheringham et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells
T Miyashita et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Signalling from adenosine receptors to mitogen-activated protein kinases
G Schulte et al.
CELLULAR SIGNALLING (2003)
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis
J Mabley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Adenosine suppresses activation of nuclear factor-κB selectively induced by tumor necrosis factor in different cell types
S Majumdar et al.
ONCOGENE (2003)
Adenosine A(2A) or A(3) receptors are required for inhibition of inflammation by methotrexate and its analog MX-68
MC Montesinos et al.
ARTHRITIS AND RHEUMATISM (2003)
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells
S Merighi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Adenosine regulates the IL-1β-induced cellular functions of human gingival fibroblasts
S Murakami et al.
INTERNATIONAL IMMUNOLOGY (2001)
Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis
T Nanki et al.
JOURNAL OF IMMUNOLOGY (2001)
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line
S Merighi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Clinical assessment of the osteoarthritis patient
G Peat et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2001)
Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts:: the dominant role for NF-κB but not C/EBPβ or c-jun
C Georganas et al.
JOURNAL OF IMMUNOLOGY (2000)
Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms
G Haskó et al.
FASEB JOURNAL (2000)
Share Paper
